drugset
drugset / Trial / NCT00169546

Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.

NCT00169546 ↗

Phase 4 Completed 64 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

Comparison of two asthma treatments by lung function measures.

Timeline

Start
2003-01
Primary completion
2005-12
Completion
2005-12

Publications

  • Background This study has not been published in the scientific literature.

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified 200 ug Inhaled
Subject Salmeterol/fluticasone propionate Unknown 50 ug Inhaled
Subject Salmeterol/fluticasone propionate Unknown 100 ug Inhaled

Indications

asthma